Rockwell Med (RMTI) Stock Statistics & Valuation Metrics

Rockwell Med has a market cap or net worth of $37.59M. The enterprise value is $36.59M.

Rockwell Med has 34,174,686 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rockwell Med’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 1.35%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Rockwell Med had revenue of 101.49M and earned -480.00K in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was 3.10M and capital expenditures -872.00K, giving a free cash flow of 2.22M billion.

Rockwell Med pays an annual dividend of ―, resulting in a dividend yield of ―

Rockwell Med upcoming earnings date is Aug 14, 2025, After Close (Confirmed).

Rockwell Med as a current ratio of 2.63, with Debt / Equity ratio of 34.05%

In the past 12 months, Rockwell Med has paid 0.00 in taxes.

Rockwell Med EV to EBITDA ratio is 20.73, with an EV/FCF ratio of 19.19.

Rockwell Med has $11.39M in cash and marketable securities with $10.73M in debt, giving a net cash position of -$657.00K billion.

Gross margin is 17.87%, with operating margin of 0.60%, and net profit margin of -0.47%.

The average price target for Rockwell Med is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy